Patient Lifetime Value and Collected Contribution

Define the version of lifetime value you mean

Revenue lifetime value describes the total revenue associated with a patient over a stated horizon. Contribution lifetime value subtracts relevant delivery costs. A net value calculation may also account for acquisition and program costs. These are different quantities, and a discussion becomes misleading if the definition changes halfway through.

For a simple scenario, average monthly collected revenue multiplied by expected months gives a revenue estimate. It assumes a stable monthly amount and does not automatically account for refunds, pauses, changing care intensity or collection failures. State the horizon and assumptions. An estimate for a new cohort should not be presented as an observed lifetime result.

A simple scenario, with the costs visible

Suppose a hypothetical program collects $250 per patient per active month for six months. The gross revenue scenario is $1,500. If relevant variable delivery costs are $150 per active month, contribution before acquisition and other program costs is $600. An additional active month would add $250 in revenue but only $100 in contribution under these assumptions.

That extra month must still be clinically appropriate, actually observed and paid. It cannot be credited to an engagement program merely because the patient received outreach. These figures are arithmetic examples, not recommended pricing, expected margins or evidence of patient continuation. Changing any input changes the result.

Use cohorts rather than one blended average

Separate patients by entry period and comparable program characteristics when reviewing value over time. A mature cohort has had more opportunity to generate collections than a newly enrolled cohort. Comparing their totals without adjusting the observation period can make a new program look weaker for purely timing-related reasons.

Track active treatment, planned pauses, transfers, completed programs and unexplained loss to follow-up separately. Membership billing may continue while care activity changes, and care may continue after a payment arrangement changes. Looking at both the care record and collections helps explain the average instead of attributing every movement to retention.

Use economics for planning, not clinical priority

Lifetime value can inform whether a program is economically workable, how acquisition spending is evaluated and which delivery costs need attention. It should not determine which patient receives urgent clinical review. Clinical concerns and agreed response deadlines require their own prioritization rules.

Evaluate the engagement program against usual follow-up where feasible. Report observed continuation and collected contribution over a defined period before extrapolating further. A first-90-days pilot can inform a near-term operating decision; it does not automatically establish multi-year patient value. Keep the observed result, incremental estimate and longer-term scenario visibly separate.

Practical review checklist

• Distinguish revenue from contribution. Collected revenue is money received. Contribution subtracts the direct costs of delivering the relevant care. A patient-lifetime estimate also needs an explicit time horizon, collection assumptions and treatment-duration assumptions.
• Make the assumptions visible. For an illustrative episode with $600 collected revenue and $360 in direct delivery costs, contribution is $240 before program fees and other overhead. This is arithmetic, not a Synarmic outcome or a benchmark. Actual cost definitions should be agreed with the practice.
• Keep care appropriateness central. Economic analysis should not reward unnecessary visits or discourage appropriate treatment changes. Assess incremental contribution with a credible comparison, alongside required care completed, patient experience and staff effort.